Specific activity:
not less than 0.02 MBq (0.5 µCi) per µg of cyanocobalamin.
Packaging and storage
Preserve in well-closed, light-resistant containers, and store in a cold place.
Labeling
Label the Capsules to include the following: the date of calibration; the amount of cyanocobalamin expressed in µg per Capsule; the amount of 57Co as cyanocobalamin expressed in megabecquerels (microcuries) per Capsule at the time of calibration; the expiration date; and the statement CautionRadioactive Material. The labeling indicates that in making dosage calculations, correction is to be made for radioactive decay, and also indicates that the radioactive half-life of 57Co is 270.9 days.
Disintegration 701:
30 minutes, testing 1 Capsule in 1 N hydrochloric acid maintained at 37 ± 2
as the immersion fluid.
Uniformity of dosage units:
meet the requirements.
Procedure for content uniformity
Determine the instrument response of each of 10 Capsules by measurement in a suitable counting assembly and under identical geometric conditions. Calculate the average radioactivity per Capsule. The radioactivity of none of the Capsules differs by more than 10% from the average. The relative standard deviation is less than 3.5%.
Radiochemical purity
Dissolve the contents of 1 Capsule in 1 mL of water, allow to stand for about 10 minutes, and centrifuge. Use the supernatant as the
Test solution. It meets the requirements of the test for
Radiochemical purity under
Cyanocobalamin Co 57 Oral Solution.
Radionuclidic purity
Dissolve the contents of 1 Capsule in 1 mL of water, allow to stand for about 10 minutes, and centrifuge. Use the supernatant. It meets the requirements of the test for
Radionuclidic purity under
Cyanocobalamin Co 57 Oral Solution.
Assay for radioactivity
Using a suitable counting assembly (see
Selection of a Counting Assembly under
Radioactivity 821), determine the radioactivity, in MBq (µCi) per Capsule, of Cyanocobalamin Co 57 Capsules by use of a calibrated system as directed under
Radioactivity 821.
Auxiliary Information
Staff Liaison :
Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (RMI05) Radiopharmaceuticals and Medical Imaging Agents 05
USP29NF24 Page 576
Pharmacopeial Forum : Volume No. 29(2) Page 397
Phone Number : 1-301-816-8305